Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design
- 4 June 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (14) , 3757-3762
- https://doi.org/10.1016/j.bmcl.2004.04.106
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A Novel Evolutionary Lineage of Carbonic Anhydrase (ε Class) Is a Component of the Carboxysome ShellJournal of Bacteriology, 2004
- Designing of Novel Carbonic Anhydrase Inhibitors and ActivatorsCurrent Medicinal Chemistry-Cardiovascular & Hematological Agents, 2004
- Review ArticleJournal of Enzyme Inhibition and Medicinal Chemistry, 2004
- Unexpected Nanomolar Inhibition of Carbonic Anhydrase by COX-2-Selective Celecoxib: New Pharmacological Opportunities Due to Related Binding Site RecognitionJournal of Medicinal Chemistry, 2003
- Carbonic anhydrase inhibitorsMedicinal Research Reviews, 2002
- Applications of carbonic anhydrase inhibitors and activators in therapyExpert Opinion on Therapeutic Patents, 2002
- Carbonic Anhydrase InhibitorsCurrent Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, 2001
- The Active Site Structure of Thalassiosira weissflogii Carbonic Anhydrase 1Biochemistry, 2000
- Carbonic anhydrase inhibitors and their therapeutic potentialExpert Opinion on Therapeutic Patents, 2000
- A biological function for cadmium in marine diatomsProceedings of the National Academy of Sciences, 2000